[go: up one dir, main page]

WO1998050067A3 - Use or a secretion vector for fertility control by oral vaccination - Google Patents

Use or a secretion vector for fertility control by oral vaccination Download PDF

Info

Publication number
WO1998050067A3
WO1998050067A3 PCT/EP1998/002679 EP9802679W WO9850067A3 WO 1998050067 A3 WO1998050067 A3 WO 1998050067A3 EP 9802679 W EP9802679 W EP 9802679W WO 9850067 A3 WO9850067 A3 WO 9850067A3
Authority
WO
WIPO (PCT)
Prior art keywords
oral vaccination
fertility control
secretion vector
vaccination
fertility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1998/002679
Other languages
German (de)
French (fr)
Other versions
WO1998050067A9 (en
WO1998050067A2 (en
Inventor
Peter Donner
Werner Goebel
Andreas Demuth
Ivaylo Gentschev
Juergen Hess
Stefan Kaufmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to PL98336786A priority Critical patent/PL336786A1/en
Priority to BR9809244-8A priority patent/BR9809244A/en
Priority to IL13252198A priority patent/IL132521A0/en
Priority to CA002288602A priority patent/CA2288602A1/en
Priority to EP98929286A priority patent/EP1015023A1/en
Priority to AU79107/98A priority patent/AU7910798A/en
Priority to JP54774098A priority patent/JP2002501507A/en
Priority to EEP199900516A priority patent/EE9900516A/en
Priority to SK1517-99A priority patent/SK151799A3/en
Application filed by Schering AG filed Critical Schering AG
Publication of WO1998050067A2 publication Critical patent/WO1998050067A2/en
Publication of WO1998050067A9 publication Critical patent/WO1998050067A9/en
Priority to IS5199A priority patent/IS5199A/en
Priority to BG103850A priority patent/BG103850A/en
Priority to NO995429A priority patent/NO995429L/en
Anticipated expiration legal-status Critical
Publication of WO1998050067A3 publication Critical patent/WO1998050067A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)

Abstract

The invention relates to a fertility-control method by oral vaccination using attenuated salmonellae or other gram-negative attenuated vaccination strains. Different systems of expression are used which enable a specific MHCII/CD4 or MHCI/CD8 immune response to be generated.
PCT/EP1998/002679 1997-05-07 1998-05-07 Use or a secretion vector for fertility control by oral vaccination Ceased WO1998050067A2 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SK1517-99A SK151799A3 (en) 1997-05-07 1998-05-07 Use or a secretion vector for fertility control by oral vaccination
IL13252198A IL132521A0 (en) 1997-05-07 1998-05-07 Use of a secretion vector for birth control by oral vaccination
CA002288602A CA2288602A1 (en) 1997-05-07 1998-05-07 Use of a secretion vector for fertility control by oral vaccination
EP98929286A EP1015023A1 (en) 1997-05-07 1998-05-07 Use or a secretion vector for fertility control by oral vaccination
AU79107/98A AU7910798A (en) 1997-05-07 1998-05-07 Use or a secretion vector for fertility control by oral vaccination
JP54774098A JP2002501507A (en) 1997-05-07 1998-05-07 Use of secretory vectors in oral vaccination for birth control
EEP199900516A EE9900516A (en) 1997-05-07 1998-05-07 Use of secretion vector for fertility control by oral vaccination
PL98336786A PL336786A1 (en) 1997-05-07 1998-05-07 Application of a secretion vector in controlling fertility by means of an orally administered vaccine
BR9809244-8A BR9809244A (en) 1997-05-07 1998-05-07 Application of a secretion vector to control fertility through oral vaccination
IS5199A IS5199A (en) 1997-05-07 1999-09-28 Use of a secretory gene for fertility control by oral immunization
BG103850A BG103850A (en) 1997-05-07 1999-11-02 The application of secreting vector for fertility control by peroral vaccination
NO995429A NO995429L (en) 1997-05-07 1999-11-05 Use of a secretion vector for fertility control in oral vaccination

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19720761A DE19720761A1 (en) 1997-05-07 1997-05-07 Process for the synthesis and secretion of proteins or protein fragments suitable for contraception by attenuated Salmonella or another Gram-negative attenuated vaccine strain to produce an oral vaccination
DE19720761.8 1997-05-07

Publications (3)

Publication Number Publication Date
WO1998050067A2 WO1998050067A2 (en) 1998-11-12
WO1998050067A9 WO1998050067A9 (en) 1999-03-25
WO1998050067A3 true WO1998050067A3 (en) 2000-06-29

Family

ID=7829783

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/002679 Ceased WO1998050067A2 (en) 1997-05-07 1998-05-07 Use or a secretion vector for fertility control by oral vaccination

Country Status (18)

Country Link
EP (1) EP1015023A1 (en)
JP (1) JP2002501507A (en)
KR (1) KR20010012257A (en)
CN (1) CN1255067A (en)
AU (1) AU7910798A (en)
BG (1) BG103850A (en)
BR (1) BR9809244A (en)
CA (1) CA2288602A1 (en)
DE (1) DE19720761A1 (en)
EE (1) EE9900516A (en)
HU (1) HUP0002752A2 (en)
IL (1) IL132521A0 (en)
IS (1) IS5199A (en)
NO (1) NO995429L (en)
PL (1) PL336786A1 (en)
SK (1) SK151799A3 (en)
TR (1) TR199902671T2 (en)
WO (1) WO1998050067A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10206325A1 (en) * 2002-02-14 2003-09-04 Medinnova Ges Med Innovationen Coated microorganism
US6989160B2 (en) * 2002-03-19 2006-01-24 Council Of Scientific And Industrial Research Therapeutic/edible compositions comprising herbal ingredients and methods for treating hyperglycemia
EP1882743A4 (en) * 2005-05-12 2012-08-01 Ajinomoto Kk PROCESS FOR PRODUCING A PROTEIN

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009684A1 (en) * 1990-11-21 1992-06-11 Washington University Recombinant avirulent salmonella antifertility vaccines
WO1995015764A1 (en) * 1993-12-10 1995-06-15 The University Of North Carolina At Chapel Hill Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009684A1 (en) * 1990-11-21 1992-06-11 Washington University Recombinant avirulent salmonella antifertility vaccines
WO1995015764A1 (en) * 1993-12-10 1995-06-15 The University Of North Carolina At Chapel Hill Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; O'GAORA P ET AL: "Yersinia enterocolitica aroA mutants as carriers of the B subunit of the Escherichia coli heat-labile enterotoxin to the murine immune system.", XP002078678 *
GENTSCHEV I ET AL: "Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway.", GENE, (1996 NOV 7) 179 (1) 133-40. JOURNAL CODE: FOP. ISSN: 0378-1119., Netherlands, XP002078662 *
GENTSCHEV I ET AL: "The Escherichia coli hemolysin secretion apparatus--a versatile antigen delivery system in attenuated Salmonella.", BEHRING INSTITUTE MITTEILUNGEN, (1997 FEB) (98) 103-13. JOURNAL CODE: 9KI. ISSN: 0301-0457., GERMANY: Germany, Federal Republic of, XP002078677 *
HESS J ET AL: "Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase.", INFECTION AND IMMUNITY, (1997 APR) 65 (4) 1286-92. JOURNAL CODE: GO7. ISSN: 0019-9567., United States, XP002078663 *
MICROBIAL PATHOGENESIS, (1990 AUG) 9 (2) 105-16. JOURNAL CODE: MIC. ISSN: 0882-4010., ENGLAND: United Kingdom *

Also Published As

Publication number Publication date
EE9900516A (en) 2000-06-15
NO995429D0 (en) 1999-11-05
TR199902671T2 (en) 2000-09-21
DE19720761A1 (en) 1998-11-12
BR9809244A (en) 2000-06-27
IS5199A (en) 1999-09-28
HUP0002752A2 (en) 2000-12-28
CA2288602A1 (en) 1998-11-12
IL132521A0 (en) 2001-03-19
AU7910798A (en) 1998-11-27
EP1015023A1 (en) 2000-07-05
NO995429L (en) 2000-01-07
CN1255067A (en) 2000-05-31
KR20010012257A (en) 2001-02-15
SK151799A3 (en) 2000-06-12
WO1998050067A9 (en) 1999-03-25
BG103850A (en) 2000-05-31
WO1998050067A2 (en) 1998-11-12
JP2002501507A (en) 2002-01-15
PL336786A1 (en) 2000-07-17

Similar Documents

Publication Publication Date Title
TW266228B (en)
EP1203817A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
GB2322801B (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
AU4078599A (en) Expression vectors for stimulating an immune response and methods of using the same
EP1170016A3 (en) Urease-based vaccine against helicobacter infection
AU3526995A (en) Vaccine compositions
WO1999036544A3 (en) Neisseria meningitidis antigens
WO1999024578A3 (en) Neisserial antigens
IL150736A0 (en) Altered strain of the modified vaccinia virus ankara (mva)
EP0955059A3 (en) Vaccines containing a saponin and a sterol
WO1998016646A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
DE69929444D1 (en) CPG COMPOSITIONS, SAPONIN ADJUVANTIES, AND METHOD OF USE THEREOF
WO1998053075A3 (en) Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
NZ335050A (en) Helicobacter pylori live vaccine
WO1998050067A3 (en) Use or a secretion vector for fertility control by oral vaccination
WO2000050073A3 (en) Caulobacter lps immunoadjuvant
WO2001035993A3 (en) Compositions and methods for stimulating an immune response against infectious agents
WO1997038711A3 (en) T-cell dependent vaccine and the cell surface receptor cd28
HK1066027A1 (en) Bacillus anthracis strain

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 132521

Country of ref document: IL

Ref document number: 98804817.5

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1/12-12/12, DRAWINGS, REPLACED BY NEW PAGES 1/12-12/12

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/009336

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1999/02671

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: 500711

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 79107/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1019997010208

Country of ref document: KR

Ref document number: 151799

Country of ref document: SK

Ref document number: PV1999-3937

Country of ref document: CZ

ENP Entry into the national phase

Ref document number: 2288602

Country of ref document: CA

Ref document number: 2288602

Country of ref document: CA

Kind code of ref document: A

Ref document number: 1998 547740

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1998929286

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09423248

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: PV1999-3937

Country of ref document: CZ

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWP Wipo information: published in national office

Ref document number: 1998929286

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1019997010208

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1998929286

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1019997010208

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: PV1999-3937

Country of ref document: CZ